Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Must Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
El remedio para las cuentas médicas sorpresa puede estar en una ley federal
A partir de un caso reportado por Kaiser Health News, expertos analizan la posibilidad de que una ley federal sea el comienzo para solucionar las tremendas cuentas sorpresa.
The Remedy For Surprise Medical Bills May Lie In Stitching Up Federal Law
The wide-ranging law has the potential to blindside many consumers whose health care comes from company and union health plans that are “self-funded,” meaning they pay claims out of their own funds.
No Gaps In Understanding: Here’s Your Primer On Medigap Coverage
Seniors often don’t realize that private insurers are required to offer Medigap policies, or supplemental insurance, only when people first sign up for Medicare.
Gastos de bolsillo impiden que más personas reciban la droga que previene el VIH
Funcionarios de salud pública están intensificando esfuerzos para que más personas puedan consumir PrEP. Pero aseguradoras ponen trabas al uso de cupones.
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.